DTG + 3TC dual therapy for the treatment Naïve patients with viral load exceeding 500,000 copies/mL:...
DTG + 3TC dual therapy for the treatment Naïve patients with viral load exceeding 500,000 copies/mL: a retrospective study
About this item
Full title
Author / Creator
Dou, Yanyun , Liao, Guangfu , Lu, Ruichao , Su, Lingsong , Lan, Ke , Meng, Zhihao , Qin, Shanfang , Huang, Wei , Xu, Yuanlong , Lv, Yu , Wen, Yuhong , Lan, Shuanglai , Zuo, Yong and Zhang, Yong
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Antiretroviral therapy (ART) has transformed HIV management, with various regimens available. Dolutegravir (DTG) plus lamivudine (3TC) dual therapy is now the one of the first line regimens.
A retrospective, observational study included treatment naïve people living with HIV (PLWH) with baseline HIV RNA viral load (VL) greater than 500,000 copie...
Alternative Titles
Full title
DTG + 3TC dual therapy for the treatment Naïve patients with viral load exceeding 500,000 copies/mL: a retrospective study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_7a804aeb80264855ad34c19e82c477d4
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7a804aeb80264855ad34c19e82c477d4
Other Identifiers
ISSN
1471-2334
E-ISSN
1471-2334
DOI
10.1186/s12879-024-09624-2
